Advertising

CareRx Corporation

CRRX-T

Analysis and Opinions about CRRX-T

Signal
Opinion
Expert
Chart
TOP PICK
TOP PICK
September 20, 2021
Canada's number one provider of pharmacy services to long term care facilities. They have over 20% market share. They are also into tele-health services. The consolidation play is still in the early stages. (Analysts’ price target is $8.81)
Show full opinionHide full opinion
CareRx Corporation (CRRX-T)
September 20, 2021
Canada's number one provider of pharmacy services to long term care facilities. They have over 20% market share. They are also into tele-health services. The consolidation play is still in the early stages. (Analysts’ price target is $8.81)
PAST TOP PICK
PAST TOP PICK
June 23, 2021
(A Top Pick Jun 16/20, Up 37%) One of his biggest positions. Still buying at these levels. Safe way to play healthcare with aging demographics and industry consolidation. Unaffected by the lockdown. Several large, transformative acquisitions. #1 institutional pharmacy player in Canada, with 20% of the market. Launching telemedicine services. Great growth for many years to come.
Show full opinionHide full opinion
(A Top Pick Jun 16/20, Up 37%) One of his biggest positions. Still buying at these levels. Safe way to play healthcare with aging demographics and industry consolidation. Unaffected by the lockdown. Several large, transformative acquisitions. #1 institutional pharmacy player in Canada, with 20% of the market. Launching telemedicine services. Great growth for many years to come.
PAST TOP PICK
PAST TOP PICK
April 28, 2021
(A Top Pick Jun 16/20, Up 34%) One of his biggest positions. Rose during pandemic. Unaffected by lockdowns. Several large, accretive acquisitions, making them the largest player in Canada at 20% of the institutional pharmacy market. Huge tailwinds with the seniors demographic. Focused strategy, well managed, more consolidation to come, plus organic growth.
Show full opinionHide full opinion
(A Top Pick Jun 16/20, Up 34%) One of his biggest positions. Rose during pandemic. Unaffected by lockdowns. Several large, accretive acquisitions, making them the largest player in Canada at 20% of the institutional pharmacy market. Huge tailwinds with the seniors demographic. Focused strategy, well managed, more consolidation to come, plus organic growth.
BUY
BUY
April 21, 2021

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Trades at under 2x sales and growth is positive. The stock is doing well. Debt remains high and they are losing money. Insiders are committed, owning 21% and continue to buy. The acquisition adds $170M to sales. Has held gains this year and is a better mid-cap name in the space. Unlock Premium - Try 5i Free

Show full opinionHide full opinion

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Trades at under 2x sales and growth is positive. The stock is doing well. Debt remains high and they are losing money. Insiders are committed, owning 21% and continue to buy. The acquisition adds $170M to sales. Has held gains this year and is a better mid-cap name in the space. Unlock Premium - Try 5i Free

PAST TOP PICK
PAST TOP PICK
March 22, 2021
(A Top Pick Apr 28/20, Up 12%) They did a 20-1 share consolidation, so the stock is up a lot, and changed their name. It's Canada biggest institutional pharmacy serving senior care. The stock was untouched by Covid, because seniors still needed their meds. Also, they made several big acquisitions, and they winning business from peers. They're launching telemedicine services and, with Think Research, will supply virtual care to seniors facilities they already serve. In the next 15 years, the number of seniors will double in Canada. This is a safe way to play Canada's demographics. CRRX fixed their balance sheet, too. It trades a reasonable PE. He owns 3% of this company.
Show full opinionHide full opinion
(A Top Pick Apr 28/20, Up 12%) They did a 20-1 share consolidation, so the stock is up a lot, and changed their name. It's Canada biggest institutional pharmacy serving senior care. The stock was untouched by Covid, because seniors still needed their meds. Also, they made several big acquisitions, and they winning business from peers. They're launching telemedicine services and, with Think Research, will supply virtual care to seniors facilities they already serve. In the next 15 years, the number of seniors will double in Canada. This is a safe way to play Canada's demographics. CRRX fixed their balance sheet, too. It trades a reasonable PE. He owns 3% of this company.
PAST TOP PICK
PAST TOP PICK
January 25, 2021

(A Top Pick Feb 24/20, Up 26%) It was Centric Health. It is a large position for him and a core holding. He would buy it again. There is powerful demographic tailwinds for them. They are consolidating a very fragmented industry in Canada. There are huge cost synergies.

Show full opinionHide full opinion

(A Top Pick Feb 24/20, Up 26%) It was Centric Health. It is a large position for him and a core holding. He would buy it again. There is powerful demographic tailwinds for them. They are consolidating a very fragmented industry in Canada. There are huge cost synergies.

HOLD
HOLD
September 28, 2020

Billy Kawasaki’s Insights - Picks from 5i Research. The company continues to transform and has done well. The market cap has grown and revenues should be over $200M next year. Debt remains high however, and it has negative cash flow. Top line growth over the next two years is expected to be in the range of 20%-30%. Unlock Premium - Try 5i Free

Show full opinionHide full opinion
CareRx Corporation (CRRX-T)
September 28, 2020

Billy Kawasaki’s Insights - Picks from 5i Research. The company continues to transform and has done well. The market cap has grown and revenues should be over $200M next year. Debt remains high however, and it has negative cash flow. Top line growth over the next two years is expected to be in the range of 20%-30%. Unlock Premium - Try 5i Free

Showing 1 to 7 of 7 entries
  • «
  • 1
  • »

CareRx Corporation(CRRX-T) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 5

Neutral - Hold Signals / Votes : 1

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 6

Stockchase rating for CareRx Corporation is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

CareRx Corporation(CRRX-T) Frequently Asked Questions

What is CareRx Corporation stock symbol?

CareRx Corporation is a Canadian stock, trading under the symbol CRRX-T on the Toronto Stock Exchange (CRRX-CT). It is usually referred to as TSX:CRRX or CRRX-T

Is CareRx Corporation a buy or a sell?

In the last year, 6 stock analysts published opinions about CRRX-T. 5 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is TOP PICK. Read the latest stock experts' ratings for CareRx Corporation.

Is CareRx Corporation a good investment or a top pick?

CareRx Corporation was recommended as a Top Pick by Stephen Takacsy, B. Eng, MBA on 2021-09-20. Read the latest stock experts ratings for CareRx Corporation.

Why is CareRx Corporation stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is CareRx Corporation worth watching?

6 stock analysts on Stockchase covered CareRx Corporation In the last year. It is a trending stock that is worth watching.

What is CareRx Corporation stock price?

On 2021-09-20, CareRx Corporation (CRRX-T) stock closed at a price of $5.82.